CX3CR1 and rheumatoid arthritis: The increased CX3CR1+ T cells in the D2T RA group did not show significant activation of the JAK-STAT pathway, nor did they exhibit changes in the expression levels of CD25 or HLA-DR compared with those in non-D2T RA group (Fig. 6c).